Investor: Andrew Spokes
Number of Assets: 135
Reporting Period: Q1 - 2025
Holdings at Report: $17,935,796,589
Return Since Report: +$1,736,551,310
Return Since Report: +9.68%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | Equity | +100% | 333,000 | 0.28% | $132.65 | $126.44 | $44,172,450 | $42,104,520 | -$2,067,930 | -4.68% |
| Agios Pharmaceuticals Inc. (AGIO) | Equity | +0.46% | 5,700,466 | 1.07% | $29.30 | $39.87 | $167,023,654 | $227,249,077 | +$60,225,423 | +36.06% |
| Aleanna Inc. (ANNA) | Equity | 0% | 78,400 | 0.00% | $0.45 | $5.29 | $35,008 | $415,050 | +$380,042 | +1085.59% |
| Alvotech (ALVO) | Equity | 0% | 199,675 | 0.01% | $9.67 | $9.55 | $1,930,857 | $1,906,896 | -$23,961 | -1.24% |
| Arcellx Inc. (ACLX) | Equity | 0% | 4,000 | 0.00% | $65.60 | $71.02 | $262,400 | $284,060 | +$21,660 | +8.25% |
| Alkermes PLC (ALKS) | Equity | +100% | 1,389,800 | 0.29% | $33.02 | $26.19 | $45,891,196 | $36,398,862 | -$9,492,334 | -20.68% |
| Alphabet Inc. (GOOG) | Equity | -19.92% | 1,666,040 | 1.67% | $156.23 | $194.23 | $260,285,429 | $323,594,949 | +$63,309,520 | +24.32% |
| Altimmune Inc. (ALT) | Equity | 0% | 27,600 | 0.00% | $5.00 | $4.12 | $138,000 | $113,712 | -$24,288 | -17.60% |
| Amicus Therapeutics Inc. (FOLD) | Equity | 0% | 16,000 | 0.00% | $8.16 | $6.07 | $130,560 | $97,120 | -$33,440 | -25.61% |
| Analog Devices Inc. (ADI) | Equity | +14.67% | 1,327,000 | 1.71% | $201.67 | $227.75 | $267,616,090 | $302,220,269 | +$34,604,179 | +12.93% |
| Aon PLC (AON) | Equity | -25.70% | 1,361,744 | 2.42% | $277.83 | $374.03 | $378,337,320 | $509,335,832 | +$130,998,512 | +34.62% |
| Aramark (ARMK) | Equity | +42.34% | 16,241,996 | 3.59% | $34.52 | $43.72 | $560,673,702 | $710,100,065 | +$149,426,363 | +26.65% |
| Ardelyx Inc. (ARDX) | Equity | 0% | 23,000 | 0.00% | $4.91 | $4.28 | $112,930 | $98,440 | -$14,490 | -12.83% |
| Arrowhead Pharmaceuticals Inc. (ARWR) | Equity | -97.49% | 15,800 | 0.00% | $12.74 | $15.93 | $201,292 | $251,615 | +$50,323 | +25.00% |
| Ascendis Pharma A/S (ASND) | Equity | +100% | 1,400 | 0.00% | $155.86 | $168.37 | $218,204 | $235,718 | +$17,514 | +8.03% |
| Axsome Therapeutics Inc. (AXSM) | Equity | 0% | 4,000 | 0.00% | $116.63 | $102.08 | $466,520 | $408,300 | -$58,220 | -12.48% |
| Beigene Ltd (ONC) | Equity | 0% | 1,100 | 0.00% | $272.17 | $291.68 | $299,387 | $320,848 | +$21,461 | +7.17% |
| Beyond Meat Inc. (BYND) | Equity | +100% | 19,000 | 0.00% | $3.05 | $3.68 | $57,950 | $69,825 | +$11,875 | +20.49% |
| Biohaven Ltd. (BHVN) | Equity | +8.69% | 4,813,167 | 0.74% | $24.04 | $13.58 | $115,708,535 | $65,362,808 | -$50,345,727 | -43.51% |
| Blueprint Medicines Corp. (BPMC) | Equity | 0% | 4,000 | 0.00% | $88.51 | $99.41 | $354,040 | $397,620 | +$43,580 | +12.31% |
| Boston Scientific Corp. (BSX) | Equity | -25.09% | 3,762,757 | 2.43% | $100.88 | $106.20 | $379,586,926 | $399,585,980 | +$19,999,054 | +5.27% |
| Bridgebio Pharma Inc. (BBIO) | Equity | +36.62% | 5,731,000 | 1.27% | $34.57 | $46.33 | $198,120,670 | $265,488,575 | +$67,367,905 | +34.00% |
| Brightspring Health Services Inc. (BTSG) | Equity | 0% | 22,000 | 0.00% | $18.09 | $20.80 | $397,980 | $457,490 | +$59,510 | +14.95% |
| C4 Therapeutics Inc. (CCCC) | Equity | 0% | 28,000 | 0.00% | $1.60 | $2.26 | $44,800 | $63,280 | +$18,480 | +41.25% |
| Capricor Therapeutics Inc. (CAPR) | Equity | 0% | 2,250,400 | 0.14% | $9.49 | $6.94 | $21,356,296 | $15,617,776 | -$5,738,520 | -26.87% |
| Cardinal Health Inc. (CAH) | Equity | +100% | 273,000 | 0.24% | $137.77 | $157.50 | $37,611,210 | $42,996,135 | +$5,384,925 | +14.32% |
| CBRE Group Inc. (CBRE) | Equity | +14.49% | 2,495,700 | 2.09% | $130.78 | $147.27 | $326,387,646 | $367,541,739 | +$41,154,093 | +12.61% |
| Centessa Pharmaceuticals PLC (CNTA) | Equity | +23.88% | 4,334,318 | 0.40% | $14.38 | $15.52 | $62,327,493 | $67,268,615 | +$4,941,122 | +7.93% |
| Cogent Biosciences Inc. (COGT) | Equity | 0% | 17,000 | 0.00% | $5.99 | $12.01 | $101,830 | $204,170 | +$102,340 | +100.50% |
| Dyne Therapeutics Inc. (DYN) | Equity | -95.64% | 10,000 | 0.00% | $10.46 | $9.90 | $104,600 | $99,000 | -$5,600 | -5.35% |
| Elanco Animal Health Inc. (ELAN) | Equity | 0% | 16,000 | 0.00% | $10.50 | $14.82 | $168,000 | $237,040 | +$69,040 | +41.10% |
| Encompass Health Corp. (EHC) | Equity | +34.27% | 619,000 | 0.40% | $101.28 | $107.56 | $62,692,320 | $66,579,640 | +$3,887,320 | +6.20% |
| Arcutis Biotherapeutics Inc. (ARQT) | Equity | 0% | 26,000 | 0.00% | $15.64 | $15.08 | $406,640 | $391,950 | -$14,690 | -3.61% |
| Autodesk Inc. (ADSK) | Equity | +8.45% | 1,997,400 | 3.35% | $261.80 | $303.67 | $522,919,320 | $606,540,471 | +$83,621,151 | +15.99% |
| Beam Therapeutics Inc. (BEAM) | Equity | +20.50% | 9,928,111 | 1.24% | $19.53 | $21.76 | $193,896,008 | $215,986,055 | +$22,090,047 | +11.39% |
| Beta Bionics Inc. (BBNX) | Equity | +100% | 3,332,220 | 0.26% | $12.24 | $14.93 | $40,786,373 | $49,750,045 | +$8,963,672 | +21.98% |
| Biodesix Inc. (BDSX) | Equity | -51.22% | 1,859,308 | 0.01% | $0.63 | $0.45 | $1,162,439 | $827,392 | -$335,047 | -28.82% |
| Bruker Corp. (BRKR) | Equity | 0% | 5,000 | 0.00% | $41.74 | $41.70 | $208,700 | $208,500 | -$200 | -0.10% |
| Canopy Growth Corp. (CGC) | Equity | 0% | 30,000 | 0.00% | $0.91 | $1.14 | $27,300 | $34,050 | +$6,750 | +24.73% |
| Cara Therapeutics Inc. (CARA) | Equity | 0% | 129,685 | 0.00% | $5.07 | $5.32 | $657,503 | $689,924 | +$32,421 | +4.93% |
| Cencora Inc. (COR) | Equity | 0% | 1,000 | 0.00% | $278.09 | $290.99 | $278,090 | $290,990 | +$12,900 | +4.64% |
| Chemed Corp. (CHE) | Equity | 0% | 400 | 0.00% | $615.32 | $467.97 | $246,128 | $187,188 | -$58,940 | -23.95% |
| Crinetics Pharmaceuticals Inc. (CRNX) | Equity | +13.01% | 4,605,098 | 0.99% | $33.54 | $31.21 | $154,454,987 | $143,702,083 | -$10,752,904 | -6.96% |
| The Walt Disney Company (DIS) | Equity | +24.12% | 5,496,223 | 3.47% | $98.70 | $121.65 | $542,477,210 | $668,615,528 | +$126,138,318 | +23.25% |
| Enanta Pharmaceuticals Inc. (ENTA) | Equity | +0.66% | 2,122,262 | 0.07% | $5.52 | $7.44 | $11,714,886 | $15,779,018 | +$4,064,132 | +34.69% |
| Evolent Health Inc. (EVH) | Equity | 0% | 14,000 | 0.00% | $9.47 | $9.83 | $132,580 | $137,620 | +$5,040 | +3.80% |
| Exelixis Inc. (EXEL) | Equity | -3.87% | 22,533,500 | 5.32% | $36.92 | $45.52 | $831,936,820 | $1,025,612,253 | +$193,675,433 | +23.28% |
| Flutter Entertainment PLC (FLUT) | Equity | +167.41% | 241,467 | 0.34% | $221.55 | $303.81 | $53,497,014 | $73,360,089 | +$19,863,075 | +37.13% |
| Forte Biosciences Inc. (FBRX) | Equity | +101.23% | 70,429 | 0.00% | $7.76 | $11.25 | $546,529 | $792,326 | +$245,797 | +44.97% |
| Full Truck Alliance Co. Ltd. (YMM) | Equity | -55.64% | 7,357,207 | 0.60% | $12.77 | $11.34 | $93,951,533 | $83,393,941 | -$10,557,592 | -11.24% |
| GE Healthcare Technologies Inc. (GEHC) | Equity | +333.06% | 537,000 | 0.28% | $80.71 | $77.44 | $43,341,270 | $41,585,280 | -$1,755,990 | -4.05% |
| Genedx Holdings Corp. (WGS) | Equity | +55.38% | 303,000 | 0.17% | $88.57 | $79.86 | $26,835,195 | $24,197,580 | -$2,637,615 | -9.83% |
| Geron Corp. (GERN) | Equity | 0% | 43,000 | 0.00% | $1.59 | $1.26 | $68,370 | $53,965 | -$14,405 | -21.07% |
| Glaukos Corp. (GKOS) | Equity | 0% | 2,600 | 0.00% | $98.42 | $94.19 | $255,892 | $244,894 | -$10,998 | -4.30% |
| Globus Medical Inc. (GMED) | Equity | +2205.56% | 83,000 | 0.04% | $73.20 | $54.42 | $6,075,600 | $4,516,860 | -$1,558,740 | -25.66% |
| Grifols S.A. (GRFS) | Equity | 0% | 28,000 | 0.00% | $7.11 | $10.13 | $199,080 | $283,500 | +$84,420 | +42.41% |
| Healthcare Realty Trust Inc. (HR) | Equity | -99.63% | 12,000 | 0.00% | $16.90 | $16.14 | $202,800 | $193,620 | -$9,180 | -4.53% |
| Healthequity Inc. (HQY) | Equity | +14964.29% | 421,800 | 0.24% | $88.37 | $96.02 | $37,274,466 | $40,501,236 | +$3,226,770 | +8.66% |
| Helix Acquisition Corp. Ii (HLXB) | Equity | 0% | 600,000 | 0.04% | $11.30 | $10.69 | $6,780,000 | $6,415,200 | -$364,800 | -5.38% |
| Hims & Hers Health Inc. (HIMS) | Equity | -5.05% | 7,953,705 | 1.50% | $29.55 | $57.50 | $235,031,983 | $457,338,038 | +$222,306,055 | +94.59% |
| Immunovant Inc. (IMVT) | Equity | 0% | 12,000 | 0.00% | $17.09 | $17.09 | $205,080 | $205,020 | -$60 | -0.03% |
| Insmed Inc. (INSM) | Equity | 0% | 3,000 | 0.00% | $76.29 | $104.04 | $228,870 | $312,120 | +$83,250 | +36.37% |
| Intra-Cellular Therapies Inc. (ITCI) | Equity | +100% | 3,055,000 | 2.58% | $131.92 | $131.87 | $403,015,600 | $402,862,850 | -$152,750 | -0.04% |
| Intuit Inc. (INTU) | Equity | +11.48% | 840,258 | 3.30% | $613.99 | $790.11 | $515,910,009 | $663,892,047 | +$147,982,038 | +28.68% |
| Iovance Biotherapeutics Inc. (IOVA) | Equity | 0% | 26,000 | 0.00% | $3.33 | $1.79 | $86,580 | $46,540 | -$40,040 | -46.25% |
| Iqvia Holdings Inc. (IQV) | Equity | +9.24% | 3,411,851 | 3.85% | $176.30 | $199.39 | $601,509,331 | $680,271,912 | +$78,762,581 | +13.09% |
| Ironwood Pharmaceuticals Inc. (IRWD) | Equity | 0% | 13,000 | 0.00% | $1.47 | $0.83 | $19,110 | $10,738 | -$8,372 | -43.81% |
| Ishares Bitcoin Trust ETF (IBIT) | Equity | -20.19% | 5,793,800 | 1.74% | $46.81 | $66.40 | $271,207,778 | $384,708,320 | +$113,500,542 | +41.85% |
| Janux Therapeutics Inc. (JANX) | Equity | 0% | 48,000 | 0.01% | $27.00 | $26.46 | $1,296,000 | $1,270,080 | -$25,920 | -2.00% |
| Joyy Inc. (YY) | Equity | +100% | 780,000 | 0.21% | $41.98 | $52.03 | $32,744,400 | $40,583,400 | +$7,839,000 | +23.94% |
| Krystal Biotech Inc. (KRYS) | Equity | 0% | 2,000 | 0.00% | $180.30 | $148.71 | $360,600 | $297,420 | -$63,180 | -17.52% |
| Lantheus Holdings Inc. (LNTH) | Equity | +13.30% | 6,023,227 | 3.76% | $97.60 | $72.92 | $587,866,955 | $439,213,713 | -$148,653,242 | -25.29% |
| Latam Airlines Group S.A. (LTM) | Equity | -9.13% | 562,010 | 0.11% | $31.28 | $35.25 | $17,579,673 | $19,810,853 | +$2,231,180 | +12.69% |
| Liquidia Corp. (LQDA) | Equity | +21.27% | 3,990,956 | 0.38% | $14.75 | $19.61 | $58,866,601 | $78,262,647 | +$19,396,046 | +32.95% |
| Livanova PLC (LIVN) | Equity | +100% | 37,000 | 0.01% | $39.28 | $43.89 | $1,453,360 | $1,623,745 | +$170,385 | +11.72% |
| Madrigal Pharmaceuticals Inc. (MDGL) | Equity | 0% | 3,319 | 0.01% | $331.23 | $300.75 | $1,099,352 | $998,199 | -$101,153 | -9.20% |
| Mara Holdings Inc. (MARA) | Equity | +50.45% | 835,000 | 0.06% | $11.50 | $16.19 | $9,602,500 | $13,518,650 | +$3,916,150 | +40.78% |
| Marblegate Acquisition Corp. (GATE) | Equity | 0% | 150,000 | 0.01% | $11.05 | $36.05 | $1,656,930 | $5,407,500 | +$3,750,570 | +226.36% |
| Mastercard Inc. (MA) | Equity | -31.89% | 201,371 | 0.71% | $548.12 | $568.79 | $110,375,473 | $114,536,804 | +$4,161,331 | +3.77% |
| Mckesson Corp. (MCK) | Equity | -9.53% | 552,500 | 2.38% | $672.99 | $712.35 | $371,826,975 | $393,570,613 | +$21,743,638 | +5.85% |
| Merit Medical Systems Inc. (MMSI) | Equity | 0% | 3,000 | 0.00% | $105.71 | $84.81 | $317,130 | $254,430 | -$62,700 | -19.77% |
| Microsoft Corp. (MSFT) | Equity | +39.97% | 2,285,835 | 5.49% | $375.39 | $517.06 | $858,079,601 | $1,181,913,845 | +$323,834,244 | +37.74% |
| Nasdaq Inc. (NDAQ) | Equity | +11.56% | 4,460,288 | 2.16% | $75.86 | $81.83 | $338,357,448 | $364,985,367 | +$26,627,919 | +7.87% |
| Natera Inc. (NTRA) | Equity | +2.62% | 4,547,809 | 4.11% | $141.41 | $139.35 | $643,105,671 | $633,737,184 | -$9,368,487 | -1.46% |
| New Oriental Education & Technology Group Inc. (EDU) | Equity | -44.68% | 1,305,150 | 0.40% | $47.81 | $46.55 | $62,399,222 | $60,748,207 | -$1,651,015 | -2.65% |
| The New York Times Company (NYT) | Equity | +21.10% | 8,932,113 | 2.83% | $49.60 | $52.64 | $443,032,805 | $470,141,768 | +$27,108,963 | +6.12% |
| Novavax Inc. (NVAX) | Equity | 0% | 16,000 | 0.00% | $6.41 | $7.45 | $102,560 | $119,120 | +$16,560 | +16.15% |
| Nuvalent Inc. (NUVL) | Equity | 0% | 150,000 | 0.07% | $70.92 | $81.86 | $10,638,000 | $12,279,000 | +$1,641,000 | +15.43% |
| Oscar Health Inc. (OSCR) | Equity | 0% | 11,000 | 0.00% | $13.11 | $14.31 | $144,210 | $157,355 | +$13,145 | +9.12% |
| Pacific Biosciences Of California Inc. (PACB) | Equity | 0% | 135,000 | 0.00% | $1.18 | $1.57 | $159,300 | $211,275 | +$51,975 | +32.63% |
| Prime Medicine Inc. (PRME) | Equity | 0% | 750,000 | 0.01% | $1.99 | $4.30 | $1,492,500 | $3,225,000 | +$1,732,500 | +116.08% |
| Progyny Inc. (PGNY) | Equity | 0% | 18,000 | 0.00% | $22.34 | $23.31 | $402,120 | $419,580 | +$17,460 | +4.34% |
| Protagonist Therapeutics Inc. (PTGX) | Equity | +2.98% | 6,107,006 | 1.89% | $48.36 | $54.94 | $295,334,810 | $335,518,910 | +$40,184,100 | +13.61% |
| Revolution Medicines Inc. (RVMD) | Equity | +2.16% | 13,534,692 | 3.06% | $35.36 | $38.01 | $478,586,709 | $514,453,643 | +$35,866,934 | +7.49% |
| Roivant Sciences Ltd. (ROIV) | Equity | 0% | 37,000 | 0.00% | $10.09 | $11.63 | $373,330 | $430,125 | +$56,795 | +15.21% |
| Rxsight Inc. (RXST) | Equity | +100% | 175,000 | 0.03% | $25.25 | $8.07 | $4,418,750 | $1,412,250 | -$3,006,500 | -68.04% |
| Sabra Health Care Reit Inc. (SBRA) | Equity | 0% | 14,000 | 0.00% | $17.47 | $18.29 | $244,580 | $256,060 | +$11,480 | +4.69% |
| Sage Therapeutics Inc. (SAGE) | Equity | 0% | 42,800 | 0.00% | $7.95 | $8.79 | $340,260 | $376,212 | +$35,952 | +10.57% |
| Salesforce Inc. (CRM) | Equity | +62.55% | 1,967,110 | 3.38% | $268.36 | $269.95 | $527,893,640 | $531,021,345 | +$3,127,704 | +0.59% |
| Sarepta Therapeutics Inc. (SRPT) | Equity | -18.28% | 2,341,424 | 0.96% | $63.82 | $11.92 | $149,429,680 | $27,909,774 | -$121,519,906 | -81.32% |
| Savara Inc. (SVRA) | Equity | 0% | 6,835,000 | 0.12% | $2.77 | $2.56 | $18,932,950 | $17,497,600 | -$1,435,350 | -7.58% |
| Silicon Motion Technology Corp. (SIMO) | Equity | -92.94% | 29,298 | 0.01% | $50.56 | $73.08 | $1,481,307 | $2,141,098 | +$659,791 | +44.54% |
| Somnigroup International Inc. (TPX) | Equity | +100% | 1,326,242 | 0.51% | $59.88 | $59.86 | $79,415,371 | $79,388,846 | -$26,525 | -0.03% |
| Springworks Therapeutics Inc. (SWTX) | Equity | +100% | 118,000 | 0.03% | $44.13 | $46.99 | $5,207,340 | $5,544,820 | +$337,480 | +6.48% |
| Syndax Pharmaceuticals Inc. (SNDX) | Equity | 0% | 10,000 | 0.00% | $12.29 | $9.57 | $122,850 | $95,690 | -$27,160 | -22.11% |
| Tectonic Therapeutic Inc. (TECX) | Equity | +19.63% | 853,050 | 0.10% | $17.71 | $22.17 | $15,107,516 | $18,912,119 | +$3,804,603 | +25.18% |
| Thermo Fisher Scientific Inc. (TMO) | Equity | -16.01% | 1,035,856 | 3.30% | $497.60 | $477.97 | $515,441,946 | $495,108,092 | -$20,333,854 | -3.94% |
| Tyra Biosciences Inc. (TYRA) | Equity | +14.27% | 1,143,818 | 0.07% | $9.30 | $11.09 | $10,637,507 | $12,684,942 | +$2,047,435 | +19.25% |
| United Therapeutics Corp. (UTHR) | Equity | 0% | 1,000 | 0.00% | $308.27 | $306.94 | $308,270 | $306,940 | -$1,330 | -0.43% |
| UnitedHealth Group Inc. (UNH) | Equity | +2.42% | 1,497,900 | 5.02% | $523.75 | $282.19 | $784,525,125 | $422,692,401 | -$361,832,724 | -46.12% |
| Verona Pharma PLC (VRNA) | Equity | +100% | 1,084,989 | 0.44% | $63.49 | $105.35 | $68,885,952 | $114,303,591 | +$45,417,639 | +65.93% |
| Voyager Therapeutics Inc. (VYGR) | Equity | 0% | 2,570,700 | 0.06% | $3.38 | $3.29 | $8,688,966 | $8,457,603 | -$231,363 | -2.66% |
| Westinghouse Air Brake Technologies Corp. (WAB) | Equity | +12.44% | 1,608,098 | 1.87% | $181.35 | $195.53 | $291,628,572 | $314,431,402 | +$22,802,830 | +7.82% |
| Waystar Holding Corp. (WAY) | Equity | +50.52% | 2,020,000 | 0.48% | $37.36 | $35.94 | $75,467,200 | $72,598,800 | -$2,868,400 | -3.80% |
| Woodward Inc. (WWD) | Equity | -6.68% | 1,419,700 | 1.66% | $182.49 | $256.93 | $259,081,053 | $364,756,423 | +$105,675,370 | +40.79% |
| Zymeworks Inc. (ZYME) | Equity | -69.92% | 400,000 | 0.03% | $11.91 | $12.43 | $4,764,000 | $4,972,000 | +$208,000 | +4.37% |
| Scholar Rock Holding Corp. (SRRK) | Equity | 0% | 7,000 | 0.00% | $32.15 | $38.98 | $225,050 | $272,860 | +$47,810 | +21.24% |
| The Charles Schwab Corp. (SCHW) | Equity | +20.95% | 3,832,857 | 1.92% | $78.28 | $97.05 | $300,036,046 | $371,978,772 | +$71,942,726 | +23.98% |
| Soleno Therapeutics Inc. (SLNO) | Equity | -94.44% | 5,000 | 0.00% | $71.45 | $86.65 | $357,250 | $433,250 | +$76,000 | +21.27% |
| Summit Midstream Corp. (SMC) | Equity | 0% | 58,214 | 0.01% | $33.89 | $25.34 | $1,972,872 | $1,475,143 | -$497,729 | -25.23% |
| Tango Therapeutics Inc. (TNGX) | Equity | +15.27% | 4,610,930 | 0.04% | $1.37 | $7.04 | $6,316,974 | $32,460,947 | +$26,143,973 | +413.87% |
| Transmedics Group Inc. (TMDX) | Equity | +100% | 3,000 | 0.00% | $67.28 | $108.24 | $201,840 | $324,720 | +$122,880 | +60.88% |
| Transunion (TRU) | Equity | +1.63% | 5,413,206 | 2.87% | $82.99 | $98.78 | $449,241,966 | $534,711,075 | +$85,469,109 | +19.03% |
| Twist Bioscience Corp. (TWST) | Equity | 0% | 7,650 | 0.00% | $39.26 | $35.39 | $300,339 | $270,734 | -$29,606 | -9.86% |
| Uniqure N.V. (QURE) | Equity | +100% | 14,000 | 0.00% | $10.60 | $15.19 | $148,400 | $212,660 | +$64,260 | +43.30% |
| Verve Therapeutics Inc. (VERV) | Equity | +100% | 912,000 | 0.03% | $4.57 | $11.13 | $4,167,840 | $10,150,560 | +$5,982,720 | +143.54% |
| Visa Inc. (V) | Equity | -13.70% | 474,210 | 1.06% | $350.46 | $357.12 | $166,191,637 | $169,349,875 | +$3,158,238 | +1.90% |
| VNet Group Inc. (VNET) | Equity | +275.25% | 2,439,120 | 0.13% | $8.20 | $8.25 | $20,000,784 | $20,110,544 | +$109,760 | +0.55% |